Bavarian Nordic Articles

US government adds $32 million to Bavarian Nordic Imvamune contract

22 May 2012

Four new drugs will change prostate cancer care, says US expert

19 February 2012

Bavarian Nordic in advanced talks to partner prostate cancer vaccine Prostvac

10 November 2010

Bavarian Nordic delivers 1 million doses of first vaccine developed under US biopreparedness program

14 July 2010

Showing 1-4 of 4 articles

Go to beginning

Previous

1

Next

Go to end

Is failure to adopt business process management putting the pharma industry at risk?
New Zealand declines Alexion's funding application for Solaris
HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
Elan makes "transformational" acquisitions and a divestment